SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001387131-18-000830
Filing Date
2018-02-27
Accepted
2018-02-27 17:20:24
Documents
3
Period of Report
2018-02-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT admp-8k_022118.htm 8-K 19760
2 ADAMIS PHARMACEUTICALS CORPORATION 2018 BONUS PLAN ex10-1.htm EX-10.1 40945
3 COMPENSATION COMMITTEE AUTHORIZATION REGARDING DISCRETIONARY COMPENSATION PAYMEN ex10-2.htm EX-10.2 2411
  Complete submission text file 0001387131-18-000830.txt   64464
Mailing Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36242 | Film No.: 18646466
SIC: 2834 Pharmaceutical Preparations